A. Collier Smyth
No más puestos en curso
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Kimberly McCutcheon Jablonski | F | - | 21 años | |
Tim Power | M | - | 18 años | |
William Perhacs | M | - | 17 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Giovanni Caforio | M | 59 | 24 años | |
Lamberto Andreotti | M | 73 | 19 años | |
Charles A. Heimbold | M | - | 20 años | |
James Cornelius | M | 81 | 10 años | |
Peter R. Dolan | M | 68 | 18 años | |
Wayne P. Yetter | M | 78 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | 6 años |
John V. Talley | M | 68 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | 11 años |
Matthew Ros | M | 57 | 20 años | |
Gerald Bruce | M | 68 | 8 años | |
Leif Valdemar Johansson | M | 73 | 13 años | |
Vicki Sato | M | 75 | 15 años | |
Norbert Riedel | M | 66 | 6 años | |
Alan Dunton | M | 70 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | 1 años |
Joseph Squicciarino | M | 67 | 22 años | |
Priya Jambhekar | F | - | 3 años | |
Togo Dennis West | M | 81 | 10 años | |
Brian Daniels | M | 65 | 14 años | |
Mark W. Durand | M | 64 | 17 años | |
David J. Helfgott | M | - | - | |
Douglas Manion | M | 64 | 11 años | |
Rosemary Crane | F | 64 | 20 años | |
Keith Brownlie | M | 71 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | 2 años |
Fouad Namouni | M | 55 | 21 años | |
Carl Decicco | M | 62 | 10 años | |
Jason Haddock | M | 54 | 14 años | |
John Tsai | M | 57 | 11 años | |
Robert Whelan | M | 72 | 4 años | |
John E. Elicker | M | 64 | 20 años | |
Lewis B. Campbell | M | 77 | 18 años | |
James Robinson | M | 88 | 29 años | |
Anthony Hooper | M | 69 | 15 años | |
Timothy Meeker | M | 77 | 13 años | |
Gerhard Waldheim | M | 76 |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | 7 años |
Charles Sigal | M | 72 | 16 años | |
Robert Williams | M | 75 | 7 años | |
Harrison Bains | M | 80 | 16 años | |
Barry J. Wolfenson | M | 57 | 23 años | |
Louis J. Freeh | M | 74 | 8 años | |
Laurie Glimcher | M | 72 | 20 años | |
Michael Grobstein | M | 81 | 13 años | |
Alan J. Lacy | M | 70 | 12 años | |
Louis Gerstner | M | - | - | |
Dean Hakanson | M | 72 | 1 años | |
Sheila Gujrathi | M | 53 | 3 años | |
Kyu-Sung Lee | M | 64 | 5 años | |
James E. Shiah | M | 64 | 3 años | |
Steven R. Arikian | M | 65 | 2 años | |
Jon Wigginton | M | 62 | 5 años | |
Allison Luo | M | 50 | 8 años | |
Antoine Grouès | M | - | - | |
Elliott Levy | M | 65 | 17 años | |
Stephen McAndrew | M | - | 8 años | |
Dimitry Nuyten | M | 48 | 5 años | |
Emmanuel Blin | M | 54 | - | |
Wendy Dixon | M | 68 | 8 años | |
Robert E. Allen | M | - | 21 años | |
Randall Owen | M | - | 6 años | |
Kirsten Detrick | F | 59 | 13 años | |
Jennifer Herron | F | 54 | 10 años | |
Gerald Crabtree | M | 83 | 7 años | |
Charles Albright | M | 66 | 12 años | |
John H. Lawrence | M | - | 18 años | |
John Shamsey | M | - | 6 años | |
Dolca Thomas | M | 53 | 4 años | |
Luisa Salter-Cid | M | 60 | 13 años | |
James Daniel Guylain Priour | M | 57 | - | |
Sam Owusu-Akyaw | M | 71 | 2 años | |
Paul Herbert Chew | M | 72 | 9 años | |
Erin E. Lanciani | F | 55 | 5 años | |
Kenneth E. Weg | M | 85 | 10 años | |
Vance D. Coffman | M | 79 | 9 años | |
Jonathan Mow | M | 59 | 2 años | |
Jeffrey Hatfield | M | 66 | 19 años | |
Anne N. Nielsen | F | 63 | - | |
Jane A. Kramer | F | 68 | 11 años | |
Holly Tyson | F | 52 | 8 años | |
Susan Mahony | M | 59 | 5 años | |
Timothy McNamara | M | 67 | 9 años | |
Joachim von Roy | M | 79 | - | |
William Jones | M | 60 | 12 años | |
Richard J. White | M | 82 | 12 años | |
Peter Nicklin | M | 61 | 14 años | |
Cheryl Capps | F | 62 | 13 años | |
Robert Peach | M | 68 | 9 años | |
Samuel Barker | M | 81 | - | |
Pablo Lapuerta | M | 60 | 1 años | |
Charles M. Urbain | M | 70 | 14 años | |
Raymond T. Keane | M | 65 | 20 años | |
Howard Feldman | M | - | - | |
Richard Colonno | M | 74 | 16 años | |
Patricia Bellinger | F | 63 | 5 años | |
Claude Nicaise | M | 71 | 25 años | |
Luigi Lenaz | M | 83 | 19 años | |
Andy Broadway | M | 54 | 3 años | |
Robert G. Petit | M | 64 | 5 años | |
Michelle Werner | F | 48 | 10 años | |
David Wishart | M | - | 10 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 100 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- A. Collier Smyth
- Red Personal